Which MS Drugs Have the Fewest Side Effects?

When considering multiple sclerosis (MS) treatments, many people want to know which drugs have the fewest side effects because managing MS is a long-term commitment and side effects can significantly impact quality of life. MS drugs vary widely in their side effect profiles, and what is tolerable for one person may not be for another. However, some MS medications are generally known to have milder or fewer side effects compared to others.

**Interferon Beta Drugs (e.g., Avonex, Rebif)**
Interferon beta medications are among the oldest disease-modifying therapies for MS. They are given by injection (intramuscular or subcutaneous) and work by modulating the immune system to reduce inflammation. Common side effects include flu-like symptoms such as fever, chills, muscle aches, and injection site reactions like redness or swelling. Serious side effects are rare but can include liver damage, blood cell abnormalities, and depression. Overall, interferons are considered relatively safe with manageable side effects, especially with proper monitoring and dose adjustments. They are often a first-line option for people newly diagnosed with relapsing MS because of their long track record and tolerability.

**Teriflunomide (oral medication)**
Teriflunomide is an oral drug that helps reduce the frequency of MS relapses. It is generally well tolerated but can cause side effects such as hair thinning, mild gastrointestinal discomfort, and elevated liver enzymes. Rarely, it may cause skin reactions or infections. Because it is taken orally, it avoids injection site issues, which some patients prefer. Its side effects tend to be mild to moderate and often improve over time.

**Ozanimod (Zeposia)**
Ozanimod is a newer oral medication that modulates immune cell movement to reduce MS activity. It is generally well tolerated, with side effects including mild infections, headache, and fatigue. It can cause a temporary decrease in heart rate when starting treatment, so monitoring is recommended initially. Ozanimod does not usually cause severe side effects and is considered to have a favorable safety profile compared to some other oral MS drugs.

**Ocrelizumab (Ocrevus)**
Ocrelizumab is an infusion therapy targeting specific immune cells involved in MS. It is effective for both relapsing and primary progressive MS. Common side effects include infusion reactions like fever or rash and increased risk of infections. There is a small increased risk of certain cancers, so regular monitoring is important. While it has more serious potential side effects than interferons or teriflunomide, many patients tolerate it well, and it is given only twice a year, which some find convenient.

**Fingolimod (Gilenya)**
Fingolimod is an oral drug that traps immune cells in lymph nodes to prevent them from attacking the nervous system. It can cause side effects such as headache, diarrhea, and increased risk of infections. More serious but less common side effects include heart rhythm changes, macular edema (eye swelling), and liver problems. Because of these risks, patients require close monitoring, especially when starting treatment.

—

**Comparing Side Effect Profiles in Simple Terms**